Acutronic Group, a group of non-affiliated companies active in neonatal ventilation, has been acquired by Apax-backed Vyaire Medical Inc., the leading pure play medical device company in the respiratory space. Financial details have not been disclosed.
Acutronic Group, consisting of Acutronic Medical Systems AG (Switzerland) and MIM Medizinische Instrumente & Monitoring GmbH, (Germany), is a global innovation leader in the area of neonatal ventilation. The group's portfolio includes the fabian® ventilator platform, the monsoon® jet ventilator, the florian® monitor and complimentary airway management devices and software solutions. Acutronic Group has a high vertical integration in that all performance-critical device components and the disposable flow sensors are manufactured in-house. In recent years, innovative Acutronic Group has grown much faster than the market, taking significant market share away from large competitors in the global neonatal intensive care market. Founded in 1981, the company is located in Germany and Switzerland and its products are distributed in more than 90 countries.
Vyaire Medical is the leading pure play medical device company in the respiratory space. With approximately US$800 million in annual sales, the company is active in manufacturing and distributing both respiratory and anesthesia/surgical consumables as well as capital equipment for respiratory diagnostics and ventilation. Headquartered in Chicago, Illinois, Vyaire Medical was formed in October 2016 as a joint venture between Becton, Dickinson and Company and Apax Partners to serve healthcare customers with innovative device and service solutions across the respiratory and anesthesia business lines. Vyaire's brands have a 65-year track record of pioneering, innovating, and advancing respiratory diagnostics, ventilation, and anesthesia delivery and patient monitoring. From industry-pioneering brands that include Bird, Bear, and Jaeger to respected industry leaders AirLife®, Vital Signs®, Viasys, and many others – Vyaire Medical has nearly 27,000 distinct part numbers recognized, trusted and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide.
Oaklins' team in Germany advised the private shareholders of Acutronic Medical Systems AG and MIM Medizinische Instrumente & Monitoring GmbH throughout the whole transaction process.
© 2019 Oaklins. Alle Rechte vorbehalten. Oaklins ist der gemeinsame Markenname von unabhängigen Unternehmen, die Oaklins International Inc. angeschlossen sind. Weitere Informationen finden Sie unter www.oaklins.com/legal